GLP-1 receptor agonists have shown the ability to reduce neuroinflammation and oxidative stresswell-recognized contributors to Alzheimers diseaseand provide neurotrophic effects in animal models of Alzheimers, the authors write, while cautioning that this needs to be verified by further clinical trials
[DOI] [PMC free article] [PubMed] [Google Scholar] 85.Molina-Jijn E., Tapia E., Zazueta C., El Hafidi M., Zatarain-Barrn Z.L., Hernndez-Pando R., Medina-Campos O.N., Zarco-Mrquez G., Torres I., Pedraza-Chaverri J
Learn about the difference between cocoa vs
4 mg: -17.5%
As such, our mission is to remove roadblocks and explore new, effective treatment approaches, said Ildiko Lingvay, MD, MPH, MSCS, Professor at the University of Texas